Baptist Gallwitz, the new president of the DDG was born in Karlsruhe in 1957 and studied medicine in Essen, Berlin and Munich. After his Habilitation on "Glucagon-like peptide-1: An incretin with potential for the treatment of diabetes mellitus type II", he was a senior physician at the University Hospital in Kiel and at the Ruhr University Bochum. There his research focused on the role of incretin hormones in patients with type 2 diabetes and their effect on the pancreas, visceral fat tissue and energy metabolism. Since 2006 he has been deputy director of Medical Clinic IV at the University of Tübingen. The research objectives of the DZD site in Tübingen are the improved assessment of the individual risk of diabetes and the development of personalized prevention strategies.